J.&J. quietly paused Covid vaccine production at a key factory, raising concern over whether it can meet commitments to developing nations.

Tuesday, February 8, 2022 11:41 AM EST

The facility has instead been making an experimental but potentially more profitable vaccine to protect against an unrelated virus.

Read the latest